Two Sigma Investments, LP Pfizer Inc Transaction History

Two Sigma Investments, LP

$59 Billion
Q3 2025

A detailed history of Two Sigma Investments, LP transactions in Pfizer Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 75,928 shares of PFE stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,928

Holding current value

$1.9 Million

% of portfolio

0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$23.29 - $25.88 $1.77 Million - $1.97 Million	75,928 New	75,928 $1.93 Million
Q1 2025 May 15, 2025	SELL	$25.01 - $27.13 $114 Million - $124 Million	-4,573,084 Reduced 86.24%	729,647 $18.5 Million
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $81.8 Million - $99.6 Million	-3,299,112 Reduced 38.35%	5,302,731 $141 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $2.95 Million - $3.35 Million	-106,579 Reduced 1.22%	8,601,843 $249 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $7.31 Million - $8.57 Million	289,408 Added 3.44%	8,708,422 $244 Million

Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $218 Million - $250 Million	8,419,014 New	8,419,014 $234 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $89.6 Million - $105 Million	2,790,951 Added 66.36%	6,996,440 $232 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $146 Million - $169 Million	4,045,162 Added 2523.07%	4,205,489 $154 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $6.32 Million - $8.22 Million	160,327 New	160,327 $6.54 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $122 Million - $148 Million	2,779,689 New	2,779,689 $122 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $210 Million - $260 Million	-4,590,528 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $54.9 Million - $81.4 Million	-1,328,803 Reduced 22.45%	4,590,528 $271 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $41.7 Million - $47.3 Million	-1,161,719 Reduced 16.41%	5,919,331 $232 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $237 Million - $267 Million	7,081,050 New	7,081,050 $257 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $229 Million - $292 Million	-6,855,513 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $12.5 Million - $14.7 Million	-394,380 Reduced 5.44%	6,855,513 $252 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $99.5 Million - $121 Million	3,302,249 Added 83.65%	7,249,893 $237 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $79.4 Million - $113 Million	-2,938,127 Reduced 42.67%	3,947,644 $129 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $94.8 Million - $108 Million	2,880,023 Added 71.9%	6,885,771 $270 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $89.4 Million - $116 Million	2,750,249 Added 219.06%	4,005,748 $144 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $33.6 Million - $37.7 Million	-908,610 Reduced 41.99%	1,255,499 $54.4 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $79.5 Million - $87.4 Million	2,120,860 Added 4903.84%	2,164,109 $91.9 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $836,491 - $953,691	21,744 Added 101.11%	43,249 $1.89 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $152 Million - $184 Million	-4,401,424 Reduced 99.51%	21,505 $948,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $13.3 Million - $15.5 Million	-417,470 Reduced 8.62%	4,422,929 $157 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $45.3 Million - $48 Million	1,361,090 Added 39.12%	4,840,399 $175 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $108 Million - $119 Million	3,479,309	3,479,309 $124 Million

Others Institutions Holding PFE

# of Institutions

3,355

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Pfizer Inc Transaction History